220 related articles for article (PubMed ID: 24974752)
1. [Impact of natriuretic peptides in current clinical practice].
Ganovská E; Špinar J; Pařenica J
Vnitr Lek; 2014; 60(5-6):474-83. PubMed ID: 24974752
[TBL] [Abstract][Full Text] [Related]
2. [Impact of natriuretic peptides in current clinical practice-editorial].
Málek F
Vnitr Lek; 2014; 60(5-6):414. PubMed ID: 25069142
[No Abstract] [Full Text] [Related]
3. [Do we need even more new biomarkers?].
Schnabel RB; Blankenberg S
Dtsch Med Wochenschr; 2013 Mar; 138(13):662-4. PubMed ID: 23512370
[No Abstract] [Full Text] [Related]
4. Circulating natriuretic peptide levels in acute heart failure.
Maisel A
Rev Cardiovasc Med; 2007; 8 Suppl 5():S13-21. PubMed ID: 18192949
[TBL] [Abstract][Full Text] [Related]
5. Natriuretic peptides in heart failure and acute coronary syndrome.
Gaggin HK; Januzzi JL
Clin Lab Med; 2014 Mar; 34(1):43-58, vi. PubMed ID: 24507786
[TBL] [Abstract][Full Text] [Related]
6. Natriuretic Peptides in Clinical Practice.
Çavuşoğlu Y; Alper AT; Altay H; Çelik A; Demirkan B; Güvenç TS; Küçükoğlu MS; Nalbantgil S; Özdemir M; Özin B; Sayın T; Yıldırımtürk Ö; Yılmaz MB; Zorkun C
Anatol J Cardiol; 2019 Mar; 21(Suppl 1):1-40. PubMed ID: 30860204
[TBL] [Abstract][Full Text] [Related]
7. [Natriuretic peptides and their use in clinical practice according to the guidelines of the European Society of Cardiology].
Stryjewski PJ; Nessler B; Paweł M; Badacz L; Nowak J; Nessler J
Przegl Lek; 2014; 71(1):33-5. PubMed ID: 24712266
[TBL] [Abstract][Full Text] [Related]
8. Natriuretic peptides in acute chest pain and acute coronary syndrome: from pathophysiology to clinical and prognostic applications.
Aspromonte N; Di Fusco SA; Latini R; Cruz DN; Masson S; Tubaro M; Palazzuoli A
Coron Artery Dis; 2013 Jan; 24(1):33-9. PubMed ID: 23164752
[TBL] [Abstract][Full Text] [Related]
9. Clinical Applications of Natriuretic Peptides in Heart Failure and Atrial Fibrillation.
Baba M; Yoshida K; Ieda M
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31185605
[TBL] [Abstract][Full Text] [Related]
10. Evolution of natriuretic peptides testing in heart failure - Impact of novel therapies.
Mitoff P
Clin Biochem; 2016 Jun; 49(9):643-644. PubMed ID: 27060498
[No Abstract] [Full Text] [Related]
11. [Natriuretic peptides for the management of patients with heart failure: a bridge between primary care and cardiology?].
D'Ambrosio G; Parretti D; De Maria R; Cricelli I; Di Tano G; Aspromonte N
G Ital Cardiol (Rome); 2016 Jan; 17(1):41-7. PubMed ID: 26901257
[TBL] [Abstract][Full Text] [Related]
12. Evolution of natriuretic peptide biomarkers in heart failure: Implications for clinical care and clinical trials.
Vodovar N; Mebazaa A; Januzzi JL; Murtagh G; Stough WG; Adams KF; Zannad F
Int J Cardiol; 2018 Mar; 254():215-221. PubMed ID: 29407093
[TBL] [Abstract][Full Text] [Related]
13. Measurement of natriuretic peptides at the point of care in the emergency and ambulatory setting: current status and future perspectives.
Bingisser R; Cairns CB; Christ M; Collinson P; Hausfater P; Lindahl B; Mair J; Price C; Venge P
Am Heart J; 2013 Oct; 166(4):614-621.e1. PubMed ID: 24093839
[TBL] [Abstract][Full Text] [Related]
14. Natriuretic peptides in acute coronary syndromes: A new role to predict recurrent ischemic event-related mortality?
Bistola V; Polyzogopoulou E; Parissis J
Hellenic J Cardiol; 2018; 59(2):119-121. PubMed ID: 29730194
[TBL] [Abstract][Full Text] [Related]
15. Changes in natriuretic peptides after acute hospital presentation for heart failure with preserved ejection fraction: A feasible surrogate trial endpoint? A report from the prospective Karen study.
Savarese G; Donal E; Hage C; Oger E; Persson H; Daubert JC; Linde C; Lund LH;
Int J Cardiol; 2017 Jan; 226():65-70. PubMed ID: 27788392
[TBL] [Abstract][Full Text] [Related]
16. Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus.
Wolsk E; Claggett B; Pfeffer MA; Diaz R; Dickstein K; Gerstein HC; Lawson FC; Lewis EF; Maggioni AP; McMurray JJV; Probstfield JL; Riddle MC; Solomon SD; Tardif JC; Køber L
J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28554908
[TBL] [Abstract][Full Text] [Related]
17. [Expert consensus on the usefulness of natriuretic peptides in heart failure.].
Nessler J; Straburzyńska-Migaj E; Windak A; Solnica B; Szmitkowski M; Paradowski M; Kaźmierczak J; Puacz E; Rozentryt P
Kardiol Pol; 2018; 76(1):215-224. PubMed ID: 29399772
[TBL] [Abstract][Full Text] [Related]
18. [Cardiac biomarkers in the critically ill].
Reith S; Marx N
Med Klin Intensivmed Notfmed; 2012 Feb; 107(1):17-23. PubMed ID: 22349473
[TBL] [Abstract][Full Text] [Related]
19. Recommendations for the use of natriuretic peptides in acute cardiac care: a position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care.
Thygesen K; Mair J; Mueller C; Huber K; Weber M; Plebani M; Hasin Y; Biasucci LM; Giannitsis E; Lindahl B; Koenig W; Tubaro M; Collinson P; Katus H; Galvani M; Venge P; Alpert JS; Hamm C; Jaffe AS;
Eur Heart J; 2012 Aug; 33(16):2001-6. PubMed ID: 21292681
[No Abstract] [Full Text] [Related]
20. [Clinical utility of natriuretic peptdies in dyspnea].
Müller C
Ther Umsch; 2009 Sep; 66(9):649-52. PubMed ID: 19725009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
